-
Diagnostics World | An international team of researchers has found that gut microbes can help diagnose gestational diabetes mellitus (GDM) as early as the first trimester of pregnancy, months earlier than is happening currently. The long-term aim of the group is to predict and prevent one of the most common pregnancy-related medical complications with adverse health implications for mother and child.
Apr 19, 2023
-
Diagnostics World News | Post-traumatic stress disorder is difficult to diagnose under the best of conditions, including knowing the triggering issues and how an individual responds to stressful events. For the mostly young and “macho” men in the military who are exposed to combat and separated from their families for many months at a stretch the obstacles—and stakes—are even higher.
Apr 18, 2023
-
Diagnostics World News | Retinal scans offer a fascinating window into the health of the body’s circulatory system and brain functioning as well as identify eye diseases that aren't visibly noticeable. Now, a new study suggests that this artificial intelligence-based technology is also good for predicting how well people are aging.
Apr 13, 2023
-
Diagnostics World News | Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas, which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread.
Apr 11, 2023
-
Diagnostics World News | Two recent studies funded by NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative reveal differences in long COVID diagnostic experiences among different racial and ethnic groups. The findings provide information about variations in symptoms and access to care.
Apr 6, 2023
-
Diagnostics World News | Circulating tumor DNA (ctDNA) holds potential as a biomarker in lung cancer clinical trials as an added and easier-to-monitor endpoint to survival rates for measuring treatment efficacy. This was one of the key findings of her most recent work, where ctDNA was also shown to outperform clinical responses assessed on CT scans in the prediction of survival.
Apr 5, 2023
-
Diagnostics World News | Illumina has released Connected Insights, a cloud-based software for tertiary analysis for clinical next-generation sequencing (NGS) data. The software is commercially available in a limited number of countries and in beta testing in the US.
Apr 4, 2023